Citation APA
Maguire, M., Gartland, M., Moore, S., Hill, A., Tisdale, M., Harrigan, R., Kleim, J.-P., Clumeck, N., Cooper, D., Gatell, J., Gazzard, B., Goebel, F., Lange, J. M., Montaner, J., Reiss, P., Rozenbaum, W., Vella, S., Beveridge, A., Duncombe, C., Gold, J., Haberl, M., Luyts, D., Rachlis, A., Marina, R., Gerstoft, J., Wandall, J. H., Elbrond, B., Molina, J.-M., Pialloux, G., Beauvais, L., Staszewski, S., Bruns, I., Hug, M., Frissen, J., Van Der Ende, M., Bosboom, M., Baas, C., Milazzo, F., Moroni, M., Panebianco, R., Clotet, B., Gatell Artigas, J. M., Gonzalez-Lahoz, J., Leal, M., Rodriguez-Lopo, C., Gandarias, B., Johnson, M., McKinlay, S., Page, V., Watkins, K., Sandstrom, E., Belsey, E. M., Darbyshire, J., Chodakewitz, J., Isaacs, R., Jonas, L., Meibohm, A., Clendeninn, N., Petersen, A.-K., Anderson, R., Coughlan, M. G., Fiddian, P., Larder, B., Millard, J., Patel, K., Athisegaran, R., Hall, L., Shortino, D., Vafidis, I., & Yeo, J. G. (2000). Absence of zidovudine resistance in anti retroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: Virological evaluation of the AVANTI 2 and AVANTI 3 studies. AIDS, 14(9), 1195-1201. doi:10.1097/00002030-200006160-00017
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/84834